This inventor holds 1 USPTO granted patent. Top assignee: Amgen Inc.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Taoues Temal-Laib: Innovator in Pharmaceutical Chemistry
Introduction
Taoues Temal-Laib is a notable inventor based in Saint Gratien, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that interact with the calcium sensing receptor. His work is essential for advancing treatments for various diseases and disorders.
Latest Patents
Taoues Temal-Laib holds a patent for "Derivatives of urea and related diamines, methods for their manufacture, and uses therefor." This invention relates to compounds represented in Formula I, pharmaceutical compositions comprising them, and methods for treating diseases or disorders related to the function of the calcium sensing receptor. The patent also covers processes for making such compounds and intermediates useful in these processes. He has 1 patent to his name.
Career Highlights
Taoues Temal-Laib is currently employed at Amgen Inc., a leading biotechnology company. His role involves research and development in pharmaceutical innovations, where he applies his expertise to create effective therapeutic solutions.
Collaborations
Throughout his career, Taoues has collaborated with esteemed colleagues, including Pierre Deprez and Christopher Harold Fotsch. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Taoues Temal-Laib is a distinguished inventor whose work in pharmaceutical chemistry is paving the way for new treatments. His contributions are vital to the ongoing advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile